Concepedia

Publication | Closed Access

A phase II evaluation of ifosfamide and mesna in unresectable diffuse malignant mesothelioma: A southwest oncology group study

DOI

42

Citations

12

References

1992

Year

Bernard L. Zidar, Barbara Metch, Stanley P. Balcerzak, H. Irving Pierce, Liboria Militello, Michael D. Keppen, Jeffrey L. Berenberg
Cancer

Abstract

Ifosfamide/mesna has modest activity in malignant mesothelioma. It could be tested using alternate dosage schedules and in combination with other agents in treating this highly resistant neoplasm.

References

YearCitations

Page 1